ArborGen Valuation Multiples

ArborGen is valued at $19M as of October 2026, a 0.8x revenue multiple. In the last 12 months, ArborGen revenue was $70M and ArborGen EBITDA was $12M.

ArborGen Overview

About ArborGen

ArborGen Holdings Ltd is a producer of tree seedling products and a provider of conventional and technology-enhanced seedlings to the forestry industry. Seedlings are sold to landowners and managers. The Company has one reportable segment, being forestry genetics. The Company’s revenues are earned from the sale of seedlings or tree stocks and logistics services to customers. The firm focuses on loblolly pine, radiata pine, and eucalyptus.


Founded

2001

HQ

New Zealand

Employees

709

Financials (LTM)

Revenue: $70M
EBITDA: $12M

EV

$57M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

ArborGen Financials

ArborGen reported last 12-month revenue of $70M and EBITDA of $12M.

In the same LTM period, ArborGen generated $12M in EBITDA and had net loss of ($5M).

Revenue (LTM)


ArborGen P&L

In the most recent fiscal year, ArborGen reported revenue of $69M and EBITDA of $2M.

ArborGen is unprofitable as of last fiscal year, with gross margin of 30%, EBITDA margin of 3%, and net margin of (11%).

See analyst estimates for ArborGen
LTMLast FY202320242025202620272028
Revenue$70M$69M$63M$66M$69M
Gross Profit-$21M$22M$20M$21M
Gross Margin-30%36%30%30%
EBITDA$12M$2M$12M($584K)$12M
EBITDA Margin17%3%18%(1%)17%
EBIT Margin0%(1%)(4%)(40%)(1%)
Net Profit($5M)($8M)($734K)($17M)($8M)
Net Margin(7%)(11%)(1%)(25%)(11%)
Net Debt-$27M---

Financial data powered by Morningstar, Inc.

ArborGen Stock Performance

ArborGen has current market cap of $19M, and enterprise value of $57M.

Market Cap Evolution


ArborGen's stock price is $0.04.

ArborGen share price decreased by 7.0% in the last 30 days, and by 52.5% in the last year.

ArborGen has an EPS (earnings per share) of $-0.01.

See more trading valuation data for ArborGen
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$57M$19M0.3%-7.0%-4.4%-52.5%$-0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

ArborGen Valuation Multiples

ArborGen trades at 0.8x EV/Revenue multiple, and 4.7x EV/EBITDA.

See NTM and 2027E valuation multiples for ArborGen

EV / Revenue (LTM)


ArborGen Financial Valuation Multiples

As of October 20, 2026, ArborGen has market cap of $19M and EV of $57M.

ArborGen has a P/E ratio of (4.1x).

LTMLast FY202320242025202620272028
EV/Revenue0.8x0.8x0.9x0.9x0.8x
EV/EBITDA4.7x26.1x4.9x(98.2x)4.9x
EV/EBITn/m(81.9x)(21.1x)(2.2x)(112.7x)
EV/Gross Profit-2.8x2.6x2.9x2.8x
P/E(4.1x)(2.5x)(25.8x)(1.1x)(2.5x)
EV/FCF11.3x(19.8x)14.4x(21.3x)80.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified ArborGen Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

ArborGen Margins & Growth Rates

ArborGen grew revenue by 1% and EBITDA by 467% in the last fiscal year.

In the most recent fiscal year, ArborGen reported gross margin of 30%, EBITDA margin of 3%, and net margin of (11%).

See estimated margins and future growth rates for ArborGen

ArborGen Margins

Last FY202420252026202720282029
Gross Margin30%30%30%31%
EBITDA Margin3%(1%)17%14%
EBIT Margin(1%)(40%)(1%)0%
Net Margin(11%)(25%)(11%)(5%)
FCF Margin(4%)(4%)1%8%

ArborGen Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth1%4%6%0%
Gross Profit Growth-(11%)3%3%
EBITDA Growth467%(105%)(2104%)(15%)
EBIT Growth(161%)874%(98%)(128%)
Net Profit Growth(71%)2176%(54%)(54%)
FCF Growth(396%)(168%)(126%)703%

Data powered by FactSet, Inc. and Morningstar, Inc.

ArborGen Operational KPIs

ArborGen's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

ArborGen's Rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

ArborGen's Rule of X is 15% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for ArborGen
LTMLast FY202320242025202620272028
Rule of 4019%15%---
Bessemer Rule of X22%15%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
G&A Expenses to Revenue-22%17%46%30%
Opex to Revenue-31%40%71%46%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

ArborGen Competitors

ArborGen competitors include AUGA Group, Gale Pacific, Fade Gıda, ICP Israel Citrus, Bioceres, Australian Oilseeds, Genvor, Murray Cod Australia, RLF AgTech and Proximar Seafood.

Most ArborGen public comparables operate across Agriculture.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
AUGA Group$58M$9M2.2x-14.8x-
Gale Pacific$108M$9M0.3x-3.8x-
Fade Gıda$21M$3M0.9x-6.8x-
ICP Israel Citrus$357K-31.5x---
Bioceres$333M($10M)0.8x1.1x(27.3x)11.0x
Australian Oilseeds$29M$324K1.2x-108.1x-
Genvor-($6M)--(4.1x)-
Murray Cod Australia$7M-6.0x---

This data is available for Pro users. Sign up to see all ArborGen competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About ArborGen

When was ArborGen founded?ArborGen was founded in 2001.
Where is ArborGen headquartered?ArborGen is headquartered in New Zealand.
How many employees does ArborGen have?As of today, ArborGen has over 709 employees.
Is ArborGen publicly listed?Yes, ArborGen is a public company listed on New Zealand Exchange.
What is the stock symbol of ArborGen?ArborGen trades under ARB ticker.
When did ArborGen go public?ArborGen went public in 2001.
Who are competitors of ArborGen?ArborGen main competitors include AUGA Group, Gale Pacific, Fade Gıda, ICP Israel Citrus, Bioceres, Australian Oilseeds, Genvor, Murray Cod Australia, RLF AgTech, Proximar Seafood.
What is the current market cap of ArborGen?ArborGen's current market cap is $19M.
What is the current revenue of ArborGen?ArborGen's last 12 months revenue is $70M.
What is the current revenue growth of ArborGen?ArborGen revenue growth (NTM/LTM) is 2%.
What is the current EV/Revenue multiple of ArborGen?Current revenue multiple of ArborGen is 0.8x.
What is the current EBITDA of ArborGen?ArborGen's last 12 months EBITDA is $12M.
What is ArborGen's EBITDA margin?ArborGen's last 12 months EBITDA margin is 17%.
What is the current EV/EBITDA multiple of ArborGen?Current EBITDA multiple of ArborGen is 4.7x.
What is the current FCF of ArborGen?ArborGen's last 12 months FCF is $5M.
What is ArborGen's FCF margin?ArborGen's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of ArborGen?Current FCF multiple of ArborGen is 11.3x.
How many companies ArborGen has acquired to date?ArborGen hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies ArborGen has invested to date?ArborGen hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to ArborGen

Lists including ArborGen

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial